TheraTears® Nutrition Improves Dry Eye Signs And Symptoms In Clinical Trial

Advanced Vision Research, Inc. today announced the publication in the journal Cornea of promising results from a pilot trial of dry eye patients taking TheraTears® Nutrition. The study demonstrated a reduction in dry eye symptoms and an increase in tear volume and tear flow for those patients taking TheraTears® Nutrition, an optimized blend of medical grade essential omega-3 oils, including eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and flaxseed oil. Symptomatic dry eye patients received the omega-3 supplement and 70% reported having no symptoms of dry eye after 90 days, as measured by a validated test called the Ocular Surface Disease Index. In the placebo group, only 7% had a complete reduction of symptoms. The study also demonstrated that supplementation with TheraTears® Nutrition, when compared to placebo, resulted in 0.10 microliters/min higher tear flow and 0.94 microliters higher tear volume, two objective parameters key to the improvement of disease in patients with dry eye.